Expression of the RBΔCDK construct mimics treatment with a highly tumor-selective cytostatic drug that has no direct effect on the host and enabled us to determine both tumor-intrinsic and extrinsic features of RB activation on cancer biology. This evidence concerns the gene RB1 and neoplasm.